Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03349086 · ClinicalTrials.gov registry record · NA

Effects of Vocal Exercises for Spasmodic Dysphonia

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT03349086: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT03349086 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03349086, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this study is to assess the effect of voice exercise and voice rest on subject's perception of vocal handicap and communicative participation following Botox injections for adductor spasmodic dysphonia.

Primary Outcome

Pre randomized condition and post 6 week and 12 week, participants will be asked to complete the Voice Handicap Index (VHI). The VHI Questionnaire (Voice Handicap Index) is a 30-item questionnaire divided into 3 subsections (Functional, Physical, Emotional) and a Total which measures the effect of voice problems on quality of life. Individuals mark each item on this 30-item questionnaire on a scale from 0-4 (0 being never and 4 being always). Points for each subscale are tallied and a total com

Interventions

  • BEHAVIORAL Voice Exercise

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2014-07-28
Est. Completion 2018-07-25
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT03349086 record still lists

NCT03349086 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Voice Exercise is the first listed.

NCT03349086 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03349086 about?

NCT03349086 is a clinical study titled "Effects of Vocal Exercises for Spasmodic Dysphonia". The purpose of this study is to assess the effect of voice exercise and voice rest on subject's perception of vocal handicap and communicative participation following Botox injections for adductor spasmodic dysphonia.

What is the current status of trial NCT03349086?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2014-07-28. Estimated completion is 2018-07-25.

What interventions are being tested in trial NCT03349086?

The interventions under investigation include: Voice Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT03349086?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03349086's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03349086, the US trial registry maintained by the National Library of Medicine. NCT03349086 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.